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Abstract
The objective of this study is to determine the potential differential effects of THC in the
DH or VH sub-regions, as well as the upstream effects on PFC neuronal activity and oscillations.
Rodents used for electrophysiology were infused with THC or vehicle in the DH or VH regions,
combined with PFC recordings. Additionally, a battery of behavioural paradigms was performed.
Deficits in short-term memory when THC was infused into both regions was observed, however
working memory was impaired with VH infusions only. This could be due to THC-induced
dysregulation in the PFC, as beta oscillations were significantly decreased selectively in the VH.
Additionally, a selective increase in anxiety-related behaviours was observed following VH THC
infusions, but not in the DH, which could be related to changes in ERK 1/2. These findings have
implications for how marijuana may differentially impact emotional vs. cognitive functions
through differential effects on hippocampal sub-regions.

Keywords: novel object recognition, y-maze, spontaneous alternations, social interaction, fear
conditioning, p70 S6 Kinase, ERK 1/2, open field, light/dark box, THC, schizophrenia,
prefrontal cortex, dorsal hippocampus, ventral hippocampus
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1 Introduction
Marijuana is the most widely abused illicit substance in the world and is typically
consumed through inhalation or ingestion. The United Nations reports around 3.8% of the
world’s population to be regular marijuana users. Due to its easy accessibility, adolescents and
young adults alike, generally perceive the drug to be relatively harmless, which may increase its
overall usage rates (Ramo et al., 2012). There are numerous well-documented side effects of
chronic marijuana usage including the development of marijuana dependence, lung
inflammation, cognitive impairments and an increased likelihood of developing symptoms of
schizophrenia (Campolongo et al., 2007, Hasin et al., 2015, Taskin et al., 2013). Thus, as more
and more nations worldwide are looking to legalize recreational marijuana use, it is imperative to
increase our understanding of the potential neuropsychiatric side-effects of marijuana exposure.
Marijuana is composed of a variety of different phytocannabinoids, the most prevalent
being delta-9-tetrahyrocannabidiol (THC) and cannabidiol (CBD). THC is considered to be the
primary psychoactive component of marijuana and a large body of evidence has shown that THC
is the component that contributes to symptoms of psychosis (Colizzi et al., 2018, D’Souza et al.,
2016, Herkenham et al., 1991, Renard et al., 2018). These effects of THC are believed to be due
to THC-induced modulation of the brain’s CB1 cannabinoid receptor (CB1R) system and
concomitant dysregulation of mesolimbic dopamine (DA) transmission (Hudson et al., 2017,
Renard et al., 2018).
The chemical structure of THC is similar to naturally occurring endocannabinoids such as
anandamide. Endocannabinoids are neurotransmitters that play a crucial role in attention,
learning and memory. Found abundantly in the hippocampus, CB1R are primarily located on
GABAergic interneurons (Masiulis et al., 2011). Once activated CB1 receptors inhibit
interneuron activity in the ventral hippocampus, increasing excitation within the hippocampus.
THC is a partial CB1R agonist and chronic excitation resultant from marijuana use, has led to
impairments in spatial learning and memory as well as emotional processing.
The hippocampus is implicated in a variety of diverse functions, including spatial and
contextual processing and emotional memory and processing. However, considerable evidence
suggests that these functions are delegated to different ventral vs. dorsal sub-regions of the
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hippocampus. For example, whereas the dorsal hippocampus plays a role in spatial cognitive
functioning (McHugh et al., 2011, Moser et al., 1995), the ventral hippocampus is more involved
in emotional affective learning (Cox et al., 2013, Henke 1990).
Additionally, the ventral hippocampus is heavily connected to various regions of the
limbic cortex. As such, over excitation of neurons within the hippocampus affects neuronal
activity in other cortical regions downstream or upstream. Importantly, the hippocampus sends
excitatory glutamatergic signals to the ventral tegmental area (VTA). Loureiro et al. (2015)
demonstrated that ventral hippocampal hyperactivity induced by direct CB1R activation causes
an increase in dopaminergic activity in the VTA. This is correlated with increased reward
salience and deficits in sociability and social recognition behaviours. Additionally, the ventral
hippocampus sends excitatory glutamatergic projections to the nucleus accumbens. CB1R
activation in the hippocampus increases glutamatergic firing in the nucleus accumbens, thereby
modulating its neuronal activity (Loureiro et al., 2016). This in turn is correlated with an
increase in saliency of aversive emotional associative memories (Loureiro et al., 2016).
Interestingly, these behavioural effects can be reversed through the infusion of a glutamate
antagonist to the nucleus accumbens (Loureiro et al., 2015). Together, this evidence strongly
implicates a role for cannabinoid signaling in the ventral hippocampus, specifically in the
modulation of affective/emotional processing and behaviours.
Both sub-regions of the hippocampus also send excitatory axon projections to the
prefrontal cortex (PFC). The PFC participates in numerous cognitive functions such as working
memory, decision making, and goal-oriented behaviour (Kesner and Churchwell, 2011). It is also
involved in affective learning such as anxiety, and the consolidation of fear related memories.
Experimental evidence has elucidated the involvement of the hippocampus influencing activation
of neurons in the PFC during such cognitive and emotional functions (Adhikari et al., 2010,
Tierney et al., 2004). In a study performed by Floresco et al. (1997), they demonstrated that a
disconnection between the hippocampus and prefrontal cortex attenuated working memory in
rats. This implicates a hippocampal to PFC interaction during executive functioning.
Additionally, synchronous theta oscillatory activity in both the ventral hippocampus and PFC is
correlated with anxiety-like behaviours (Adhikari et al., 2010), further demonstrating the
importance of the hippocampal to PFC pathway in cognitive and emotional functioning. Thus,
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the aim of this literature review is to explore the neural mechanisms that underlie marijuanainduced deficits, with a focus on the limbic cortex.

1.1 Prevalence of Marijuana Consumption

As stated previously, marijuana is the most widely used drug product in the world. There
are about 183 million marijuana users annually and this number has not changed in the past
decade (UNODC, 2017). However, North and South America together show a prominent
increase in marijuana users from 37.6 million people in 2005 to 49.2 million in 2015 (UNODC,
2017). This rise appears to be most pronounced in the United States.
In the United States of America, 22.2 million people have reported using it within a
month according to a 2015 National Survey on Drug Use and Health. The prevalence of daily or
almost daily users went from 1.9% in 2002 to 3.9% in 2015 (UNODC,2017). It is increasingly
more prevalent among men than in women (Carliner et al., 2016).
Marijuana is most commonly abused within the adolescent to young adult age bracket. In
a 2016 survey, 35.6% of those in their 12th grade of high school reported smoking marijuana
within the past year; 22.5% within the past month (Johnston et al., 2016). In fact, the age of
initial marijuana consumption has been getting progressively younger, as a total of 2.5 million
people aged 12 or older consumed marijuana for the first time in the past 12 months in 2014
(CBHSQ, 2015).

1.2 Effects of Acute and Chronic Marijuana Consumption

Marijuana exposure is linked to a wide variety of psychological effects, both on
emotional processing and in terms of cognition. Some acute consequences of marijuana
consumption include impaired short-term memory, impaired attention, and an increase in anxiety
and paranoia. Marijuana also has been shown to have long lasting effects on learning and
memory even after the drug has worn off. As a result, an individual who smokes marijuana daily
can be functioning at a reduced intellectual level (Schweinberg et al., 2008). There is evidence to
suggest students who smoke marijuana daily have poorer educational outcomes than their nonsmoking peers. In a case control study, heavy marijuana users were compared to a control group
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who reported smoking marijuana at least once in their life but not more than 50 times. There
were significant differences found in their educational attainment; the heavy marijuana users
were less likely to complete college and had a yearly income of less than $30,000 (Gruber et al.,
2003). Heavy marijuana use is also linked to unemployment, criminal behaviour and a perceived
lower quality of life. There is also an increased chance of developing dependence, using other
drugs, and attempting suicide (Brook et al., 2013, Fergusson et al., 2008).
As mentioned above, frequent consumption of marijuana can not only affect one’s
socioeconomic status but can also be a gateway to using other commonly abused drugs. For
example, individuals who frequently used marijuana were more likely to develop an opioid use
disorder (Olfson et al., 2018). Additionally, adolescent rats pretreated with THC had a significant
increase in heroin-seeking behaviour during adulthood (Ellgren et al., 2007). This evidence
suggests that THC exposure may sensitize the brain to the reward-producing effects of opioids.
Increased marijuana usage has also been linked to the increased likelihood of developing
mental health problems in later life (Renard et al., 2017). In fact, our lab has shown that exposure
to THC induced long-term deficits in sociability, reduced exploratory behaviour, increase in
anxiety, and deficits in prepulse inhibition, all of which are anecdotal to symptoms of
schizophrenia (Renard et al., 2017). These rats were chronically exposed to THC during
adolescent time period demonstrated cognitive and emotional functioning deficits during
adulthood, increasing the probability of developing schizophrenia (Renard et al., 2016, Renard et
al., 2017).
Moreover, THC can increase the severity of symptoms in individuals predisposed with
schizophrenia. For example, in a study performed by Rodriguez et al., (2017) mice were given a
neonatal administration of phencyclidine (PCP) or saline. Administering PCP during critical
developmental periods can mimic symptoms of schizophrenia when the rodents are older. On
post-natal day 53 mice were then given sub-cutaneous injections of THC or saline for 45
consecutive days. The mice given PCP and saline displayed behavioural deficits in the Morris
water maze and pre-pulse inhibition paradigms, consistent with schizophrenia-type disorders.
The mice given PCP then THC later in life also displayed deficits in the locomotor paradigm,
novel object recognition, Morris water maze and pre-pulse inhibition. Moreover, these deficits
were greater than the ones seen in the mice that were only administered PCP.
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1.3 Cognitive Impairments Induced by THC Exposure

The literature with regards to the association between marijuana and cognition is
inconsistent. Some studies show marijuana users display relatively poorer cognitive performance
(Bolla et al., 2002). Other studies report no significant effects of THC on cognition (Ruhl et al.,
2014). These inconsistencies may be because marijuana only affects certain aspects of cognition.
For instance, there might be a modest but reversible impact on global memories but a more
deleterious effect on specific sub-domains such as verbal and/or visual memory processing.
Moreover, marijuana containing higher THC content has been shown to produce more
pronounced deficits and longer lasting effects (Pope et al., 2010). Bolla et al., (2002) performed a
battery of neurocognitive tests on heavy marijuana users and observed a dose-dependent
relationship. Those who smoked more marijuana joints per week displayed a decreased
performance in verbal and visual memory tasks, executive functioning and psychomotor speed
(Bolla et al., 2002). Additionally, while some studies report these cognitive deficits being
reversible after 28 days (Pope et al., 2001), the study performed by Bolla et al., (2002) observed
these deficits lasted longer than 28 days; this is further evidence that the higher the marijuana
consumption, the greater the severity of cognitive deficits. Moreover, the greater the THC
concentration the more severe the ensuing cognitive deficits (Pope et al., 2001).
These reports are consistent with a wide body of evidence demonstrating that THC is the
main component of marijuana responsible for inducing deficits in cognition. For example,
repeatedly injecting adolescent mice with THC demonstrated deficits in spatial memory
(Schreiber et al., 2018). This is demonstrated in non-human primates as well. For example, in
Rhesus monkeys, chronic injections of THC caused deficits in response inhibition and a loss of
control over impulsive behaviours (Jacobs et al., 2016).
Although THC is the main component of marijuana responsible for cognitive deficits, it
is selective with regards to what forms of cognition become impaired. As mentioned above THC
impairs spatial memory (Ruhl et al., 2014, Schreiber et al., 2018). The literature is inconsistent as
to whether or not it impairs associative memories (Renard et al., 2017, Ruhl et al., 2014).
Zebrafish given an acute dose of THC displayed no differences in a colour discrimination (Ruhl
et al., 2014), however adult rats chronically given THC as adolescents displayed deficits in a
novel object recognition paradigm (Renard et al., 2017). Many explanations can be offered to
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explain this variation. Perhaps acute administration of THC shows no effect on associative
memories, but chronic administrations displays deficits. Additionally, these deficits seem to be
dose-dependent, hence a lower THC concentration may not exhibit deficits. Moreover, the colour
discrimination task tested long term memory effects whereas novel object recognition tested for
short-term memory.
Additionally, memory processing is composed of various stages (e.g. encoding, recall
and extinction) and THC may not exert its effects on all processing stages. In an interesting study
done by Ranganathan et al., (2017), participants were given THC intravenously and asked to
participate in a verbal learning and memory task. This task was administered either before or
during THC administration. The study reported that the participants were impaired in memory
encoding but not in recall. In other words, only those given THC before the task demonstrated
memory impairments. Likewise, in the study performed by Renard et al., (2017), THC was
administered before performing any behavioural paradigms, another suggestion of THC affecting
memory encoding and possibly not recollection.
Higher executive functioning may also be impacted by THC administration. For example,
THC consistently affected working memory regardless of acute or chronic administration
protocols (John et al., 2018, Keeles et al., 2017, Tunbridge et al., 2015). Interestingly, in an early
study done by Hart et al., (2001) participants who smoked marijuana showed no noticeable
impairments in cognitive flexibility. However, it could be because the task used to measure
cognitive flexibility was too simplistic. Indeed, later studies using more complex measurements
of cognitive function did observe impairments in cognitive flexibility (Egerton et al., 2005,
Kangas et al., 2016, Sokolic et al., 2011). For example, in reversal learning paradigms
participants need to display a strong ability to reverse previously related associations between a
stimulus and reward. Rats administered THC displayed deficits in reversal learning thereby
demonstrating cognitive inelasticity (Egerton et al., 2005, Sokolic et al., 2011).

1.4 Emotional Learning and Memory Impairments Induced by THC Exposure

In addition to cognitive impairments, THC can also alter the processing of emotional
information. Specifically, THC is known to induce anxiety. Mice given both acute and chronic
injections of THC display increased anxiety, as they tend to spend less time and make less arm
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entries in the open arms of an elevated plus maze (Kasten et al., 2017, Murphy et al., 2017). This
effect appears to be dose dependent, as lower doses seems to reduce stress whereas higher doses
increases stress as well as a negative mood overall (Childs et al., 2017). The amount of stress felt
also impacts the amount of anxiety expressed. Fukos et al., (2009) demonstrated that in stressed
conditions, rats on high doses of THC were prone to anxiolytic-like behaviours, whereas low
doses of THC induced anxiogenic effects. Similarly, with the cognition studies, in the research
mentioned here THC was given right before beginning the behavioural paradigms, suggesting
THC affects the encoding phase of emotional learning and memory.
Not all emotionally processed information is affected by THC in the same way. For
example, in a study by Ballard et al., (2012), human participants were given THC and then asked
to perform tasks assessing facial emotion recognition. They found that THC significantly
impaired recognition of fear and angry faces but only marginally impaired recognition of sadness
and happiness (Ballard et al., 2012). This may suggest that THC affects specific, emotional
processing circuits in the brain.
In addition to negative, aversive learning phenomena, THC directly interacts with the
endocannabinoid system in the brain, responsible for reward-related learning. As such, THC,
which causes maladaptive endocannabinoid signaling, can increase the development of addictive
and drug-seeking behaviours (Rameakers et al., 2016). Additionally, marijuana consumption has
been associated with a lack of motivation and non-drug rewarding deficits, though these effects
have been poorly studied. For example, in a study performed by Lawn et al., (2016), individuals
consuming marijuana demonstrated a decreased likelihood to make high effort choices to receive
a monetary reward, thereby showcasing a lack of motivation. With the impending legalization of
marijuana, it would be interesting to explore these effects deeper by understanding the brain
regions that modulate these THC influenced deficits.

1.5 Pinpointing Brain Regions affected by THC

So far, the studies described above have only quantitatively measured the cognitive and
behavioural effects of THC. These behavioural deficits have yet to be tied to specific neural
mechanisms in the brain. Importantly, since THC is a CB1R partial agonist, it will influence
brain regions with high CB1R concentrations, such as the limbic cortex. In fact, THC exposure
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causes altered glucose utilization in the nucleus accumbens, basolateral amygdala and the
hippocampus, all critical regions of the limbic cortex (Whitlow et al., 2013) involved in
mediating stress, reward and certain aspects of memory. Thus, the limbic cortex is an area of
great interest in determining the specific neural mechanisms of THC-induced deficits.
THC can directly activate the mesolimbic dopamine system (Tanda et al., 1997), and can
potentiate brain reward phenomena (Gardner et al., 1988). Similar to drugs such as cocaine,
heroin and nicotine, THC produces its rewarding actions in the ventral tegmental area (VTA) and
nucleus accumbens shell (NaS); the VTA being the origin of the mesolimbic dopamine system
and the NaS being the region where most dopamine fibers terminate (Zangen et al., 2006). This
rewarding effect is induced due to the increased VTA dopamine neuronal activity caused by
THC exposure (Renard et al., 2017).
While dopamine neurons are known to play a pivotal part in the brain-reward circuit,
another cell type that is understudied but does have a crucial role in the reward circuit are
GABAergic neurons. CB1 receptors are commonly located on GABA neurons, thus it is possible
THC works directly on GABA neuron activity. This turns out to be true as THC in the VTA can
decrease GABAergic neuron activity, thereby increasing dopamine activity downstream which
results in an increase in reward sensitivity (Friend et al., 2017).
The effects of THC in the VTA and NaS do little to explain the cognitive and anxiety
impairments caused by this drug. The prefrontal cortex (PFC), a part of the limbic cortex, plays a
pivotal role in both cognitive processes as well as emotional learning and memory. It is
responsible for executive functions such as working memory, attention and cognitive flexibility.
Hence, cognitive deficits observed from systemic administration of THC can be traced back to
the PFC. In fact, CB1R agonist WIN-55, 212-2 modulates bursting mode firing during affective
processing which in turn increases responses to fear conditioned cues (Laviolette and Grace,
2006).

1.6 The Role of Cortical Oscillation States in Cognitive and Emotional Processing

One way of measuring neuronal population activity is by looking at brain wave
oscillations. Oscillations are studied through local field potentials (LFPs) which represent the
activity of a collection of nearby neurons (Buzaki, 2004). Synchronized LFPs are most common
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during cognitively demanding tasks (Buschman and Miller 2007). Beta (15-30 Hz) and low
gamma (30-80 Hz) oscillations have been associated with higher cognitive functions such as
working memory and cognitive flexibility (Glykos et al., 2015, Stanley et al., 2018). Beta wave
synchrony helps to construct category ensembles, a task that requires some cognitive flexibility
(Stanley et al., 2018).
Specifically, within the PFC, these oscillations seem to be modulated by GABA
neuronal activity (Glykos et al., 2015). Chronic administration of THC attenuates GABAergic
function in the PFC, leading to a hyperactive state (Renard et al., 2017). This also leads to a
decrease in gamma oscillatory activity; gamma oscillations are often associated with emotional
memory information processing (Renard et al., 2017). It is possible that THC may alter
GABAergic neuron morphology, thus decreasing their function. An interesting study done by
Kolb et al., (2018) saw chronic injections of THC altered dendritic arborisation and spine density
in the PFC.
CB1 receptors are also abundantly found in the hippocampus, a pivotal region of the
limbic cortex. Similar with the PFC, the CB1 receptors are also found on GABA neurons and
once activated, will cause a decrease in excitatory activity. Activation of the CB1 receptors by
the CB1R agonist CP55940 reduced power of local field potential oscillations and reduced spike
timing coordination (Robbe et al., 2006). This alteration of neuron activity could be associated
with marijuana-type deficits. Furthermore, the hippocampus can be divided into two regions, the
ventral hippocampus (VH) and dorsal hippocampus (DH). The VH is responsible for more
affective type learning and memory while the DH is responsible for cognition. Specifically,
when the VH is lesioned, rats tend to freeze significantly longer in a fear conditioning paradigm
(Cox et al., 2013). Meanwhile, when the DH is lesioned, rats demonstrate impairments in the
Morris water maze (McHugh et al., 2011).
Oscillatory activity in the hippocampus is thought to play a role in memory acquisition as
well as consolidation. Gamma oscillations are frequently associated with associative memory
encoding (Trimper et al., 2017), as well as anxiety and emotional memory processing (Headley
& Pare, 2013). In fact, these oscillations are generated during events that elicit an emotionally
aroused behaviour (Headley and Pare, 2013). Beta oscillations are associated with a neuronal
network tuned for novelty and this in turn may allow for new learning to occur (Franca et al.,
2014).
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1.7 Molecular Pathways Involved in Cannabinoid Control of Emotional and Cognitive
Processing

Numerous molecular signaling pathways have been linked to the ability of THC to
modulate cognitive and affective processing. As previously stated, THC is a partial agonist to the
CB1R, located on presynaptic neurons. These receptors have a role in the modulation of the
extracellular signal-related kinase (ERK) pathway activity (Derkinderen et al., 2003). ERK, a
mitogen-activated protein kinase, plays a role in synaptic plasticity and is responsible for the
induction of long-term potentiation (LTP). Therefore, blocking CB1R activation reduces
activation of ERK1/ERK2 subtypes, resulting in a decrease of synaptic markers (Karanian et al.,
2005).
ERK activity also modulates synaptic output, implicated in learning and memory
formation. Particularly, ERK is involved in reward reinforcement. Zhang et al., (2016)
demonstrated CB1R antagonism attenuated the acquisition of morphine-induced conditioned
place preference, along with a downregulation of ERK in the hippocampus and nucleus
accumbens. Hence, it can be speculated that ERK activation via CB1 receptors is part of the
underlying mechanism behind reward learning and memory, therefore involved in associative
learning.
In terms of the functional relationship between ERK activation and THC exposure,
prolonged THC exposure has been shown to induce an increase in phosphorylated ERK
expression in the hippocampus and prefrontal cortex, thereby increasing synaptic plasticity
(Rubino et al., 2005). Additionally, inhibiting ERK activation paralleled a lack of tolerance to
THC-induced hypolocomotion suggesting its role for THC-induced tolerance (Rubino et al.,
2005).
Another pathway modulated by CB1R is the mammalian target of rapamycin (mTOR)
pathway, involved in synaptic plasticity and memory formation (Hoeffer and Klann, 2010).
Chronic adolescent THC exposure was reported to dramatically decrease PFC expression levels
of mTOR, concomitant with affective and cognitive schizophrenia-like deficits (Renard et al.,
2016). Interestingly, blocking mTOR activation using rapamycin- an mTOR inhibitor- negates
the effects of THC, suggesting mTOR is involved in marijuana-induced deficits (Ibarra-Lecue et
al., 2018). The protein mTOR also regulates protein translation via activation of p70S6 kinase
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(Ma and Blenis, 2009). Chronic exposure of THC during adolescence causes a decrease in
phosphorylated p70S6 kinase in the PFC during adulthood (Renard et al., 2017). This is resultant
of an increased stimulation of dopamine receptors, which downregulates p70S6 kinase in the
PFC (Fasano et al., 2008).
P70S6 kinase activation has a positive correlation with fear retrieval in the basolateral
amygdala (BLA), suggesting enhanced fear retrieval is associated with an increased activation in
the BLA (Zubedat and Akirav, 2017). Even within the dorsal hippocampus, there is an
upregulation of p70S6 kinase during context dependent fear retrieval (Gafford et al., 2013). THC
has been noted to cause an increase in anxiety and emotional saliency and as such, may have
differential effects on p70S6 kinase expression in different limbic regions.

1.8 Hippocampal-Prefrontal Cortex Pathway

During the formation of memories or performance of mental tasks, various brain regions
need to communicate with each other to process and extract the necessary environmental
information. As a result, abnormal activity in one brain region may affect the downstream or
upstream regions it sends axonal projections to. As mentioned previously, THC acts upon the
limbic reward circuitry, responsible for reward seeking and impulsive behaviours. First of all, the
VTA sends dopaminergic projections to the NAc, which then sends glutamatergic projections to
the medial PFC (Figure 1). Ramaekers et al., (2016) demonstrated that THC decreases
connectivity of the NAc to the PFC as well as increasing impulsivity, suggesting a role of the
NAc to PFC pathway in THC-induced impulsive behaviours. Additionally, the PFC and BLA
send excitatory projections to the NAc and this effect was inhibited by THC (Pistis et al., 2002),
which may play a role in the rewarding aspects of marijuana.
The PFC will also directly send excitatory glutamatergic projections to the VTA and
conversely, dopamine neurons from the VTA will send signals to the PFC (Figure 1). Pistis et al.,
(2002) reported acute THC administration increased dopamine output to the PFC, demonstrating
aberrant cannabinoid activity can modulate neuronal activity in the PFC. This in turn may cause
aberrancies in emotional saliency and memory formation.
Another circuit involved in the processing of emotionally salient memories is the BLA to
PFC circuit (Figure 1). Both brain regions contain high levels of CB1 receptors, which modulate
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the dopamine neurotransmitter system, involved in addictive behaviours and the neuropathology
of various psychiatric disorders. Aberrant endocannabinoid signalling in the BLA-PFC pathway
may lead to dysregulation of dopamine neurotransmission (Tan et al., 2014). Behaviourally, this
may lead to disruptions in emotional processing, learning and memory, all of which are involved
in neuropsychiatric disorders.
The hippocampus is widely connected to a variety of brain regions involved in both
cognition and emotional processing (Figure 1). Parallel to the sub-region function the DH,
involved in cognitive functions, has some of its projections with the cingulate and orbital cortical
areas and VH, involved in affective behaviour, is closely connected to the amygdala and nucleus
accumbens (Caliskan & Stork, 2018).
Glutamatergic projections
Dopaminergic projections
GABAergic projections

Prefrontal
Cortex
Hippocampus

NA
VTA
Amygdala

Figure 1 Limbic cortex emotional learning and cognitive functioning pathways.

Hippocampal CB1 receptor activation via WIN-55- a receptor agonist- sends an increased
amount of excitatory projections, thereby increasing cell firing in the NaS (Loureiro et al., 2016).
This led to an aberrant amplification of emotionally salient memories, specifically in fear and
reward related memories (Loureiro et al., 2016. Similarly, VH CB1R activation increases VTA
dopamine cell firing and bursting while simultaneously decreasing VTA non-dopamine neurons
(Loureiro et al., 2015). With regards to behaviour, this increases reward saliency while causing
deficits in sociability and social recognition (Loureiro et al., 2015).
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Communication between the hippocampus and PFC is responsible for higher cognitive
functioning such as working memory and attention. Both dorsal and ventral hippocampal subregions send excitatory glutamatergic signals to the medial prefrontal cortex (mPFC). This
induces an excitatory response in the pyramidal cells of the PFC (Degentais et al., 2003). A study
by Degentais et al., (2003) also observed an inhibitory response after the excitation, suggesting
an engagement of pyramidal and non-pyramidal neurons that may constrain the excitation in
response to the hippocampal inputs.
While there is limited research involving pharmacological interventions in the
hippocampal-PFC pathway, there have been multiple studies observing oscillatory activities.
These oscillations are often linked to various cognitive and emotional processes. Hippocampal
theta (4–8 Hz) and gamma (30–80 Hz) oscillations play a fundamental role in coordinating
assembly firing across the hippocampo-prefrontal cortical regions and are believed to be critical
for working memory and encoding episodic memories (Robbe et al 2006). Theta oscillations also
work in combination with alpha oscillations (8-13 Hz). This theta-alpha wave combination binds
together hippocampal and PFC activity during memory retrieval (Herwig et al., 2016).

1.9 Research Hypothesis

The primary research objective of the thesis project was to pinpoint a specific neural
basis for THC-induced deficits in cognition and emotional learning, focusing in on the
hippocampus-prefrontal cortex pathway. As discussed above, the hippocampal formation is a
critical region of interest associated with marijuana-induced neuropathology as well as its
anatomical sub-regions, and their distinct roles in cognitive and emotionally-motived learning
and memory.
The overarching goal of the thesis is to determine the potential differential behavioural,
neuronal and molecular effects of THC in the DH vs. VH, and how these effects may modulate
hippocampal regulation of the PFC in terms of PFC cell activity and oscillatory activity states.
My General Hypothesis is that THC directly infused into the VH or DH will result in
differential effects on cognitive and affective processing through dissociable modulation of the
PFC. The hypothesis has been addressed with the following Specific AIMS:
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Aim 1: Characterize the effects of THC exposure in the DH or VH on select measures of
spatial and non-spatial cognitive functioning, and emotional/affective memory processing.

Aim 2: Characterize the effects of DH and VH THC exposure on upstream PFC neuronal
activity patterns and oscillatory states associated with emotional and cognitive processing.

Aim 3: Characterize the effects of THC exposure on protein levels in the DH and VH
associated with learning and memory processing.

2 Methods

2.1 Animals and Housing

Male adult Sprague Dawley rats (PND 75) were obtained from Charles River
Laboratories (Quebec, Canada). At arrival rats were pair housed under controlled conditions (12hour light/dark cycle, constant temperature and humidity). Food and water was provided ad
libitum. All experimental protocols and procedures were approved by the Canadian Council on
Animal Care and Animal Care Committee at University of Western Ontario.

2.2 Neuronal Activity Recording and Analysis

Extracellular single unit electrophysiological recordings were performed in vivo in the
adult rodents. In total 36 rats were used for this experiment and were separated in the following
groups: VH-VEH- 8, VH-THC- 10, DH-VEH- 7, DH-THC-11.
The recordings were taken from glutamatergic (GLUT) mPFC neurons and THC/VEH
infusions were made at either VH or DH. Rats were anesthetized with urethane (1.4g/kg, i.p.,
Sigma-Aldrich) and placed onto a stereotaxic frame with body temperature maintained at 37C.
An incision at the scalp was made and a hole was drilled in the skull overlaying the targeted
structure at the following coordinates: mPFC: AP +2.5 to +3.4 mm from bregma, LM: ±0.8 mm,
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DV: -2.5 to 4.5 mm from the dural surface. Recordings were taken with glass electrodes (average
impedance of 6–10 MΩ) filled with 2M sodium acetate solution containing 2% pontamine sky
blue (Sigma-Aldrich). Extracellular signals were amplified (×5000) using a MultiClamp 700B
amplifier (Molecular Devices), digitized at 25 kHz and recorded on the computer using a
Digidata 1440A and pClamp software (Molecular Devices). The wideband signal of PFC
recordings was fed to two channels of the digitizer and filtered to obtain single unit recordings
(band pass between 0.3 and 3 kHz) and local field potentials (LFPs; low pass at 0.3 kHz).
GLUT mPFC pyramidal neurons were identified based on established criteria: firing
frequency <10 Hz, waveform shape, action potential duration >2.5 ms. Cells exhibiting 2 or
more consecutive spikes with an interspike interval of < 45 ms were classified as burst firing
cells. The electrophysiological properties of spontaneously active pyramidal neurons were
sampled in the mPFC by making vertical passes of the electrode through the pyramidal cell body
region. Once an individual GLUT neuron was located its baseline activity was recorded for 5
minutes. For intra-VH or DH micro infusions of VEH or THC (100 ng/0.5 μl), a 10 μl Hamilton
syringe was slowly lowered into the VH or DH using the following coordinates: DH: AP – 4.3
mm from bregma, LM: ±2.8 mm, DV: -2.5 mm from the dural surface; VH: AP: -5.6 mm from
bregma, LM: ± 5 mm, DV: -6.8 mm from the dural surface. Cellular activity was recorded for 30
minutes post infusion. The basal firing rate and bursting rate were sampled.
LFP signals were analyzed using Neuroexplorer (Nex Technologies). First of all, the
signals were decimated to 1000 Hz and lowpass filtered (IIR Butterworth filter at 100 Hz; filter
order set to 3). A spectrogram function was used to calculate the power of oscillations at
frequencies between 0-100 Hz (window length 1 s; shift 0.5 s). One minute long recording
epochs were utilized for estimating the average power spectrum distribution. Power values for a
given frequency were averaged over time of the recording epoch and normalized such that the
sum of all power spectrum values equated to one. The total power was calculated by adding all
the power values at the frequencies between 0-59 and 61-100 Hz. Power values surrounding 60
Hz were excluded from all calculations. Delta waves were defined as 1-4 Hz, theta waves were
4-8 Hz, alpha waves were 8-13 Hz, beta waves 13-30 Hz and finally gamma waves 30-100 Hz.
For histological analyses, the recording electrodes positions were marked with an
iontophoretic deposit of pontamine sky blue dye (-20 mA, continuous current for 15-20 minutes).
Afterwards the rat was decapitated, brain harvested and placed in a formalin solution. Coronal
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sections (60 μm) containing either the mPFC, DH, and VH were cut on a cryostat and slide
mounted. They were later stained with a neutral red staining dye (Figure 2).

A

B

C

Figure 2 Visual representation of THC micro-infusions in the A) Ventral hippocampus, B) Dorsal hippocampus and
electrode placement in the C) Prefrontal cortex.

2.3 Surgical Procedures
Surgical procedures began at least 3 days after arrival once the rats had weighed at least
300 g. Rats for behavioural testing were anesthetized with an intraperitoneal injection of
ketamine (80 mg/mL, Vetoquinol)- xylazine (6 kg/kg, Bayer) mixture. To reduce pain and
inflammation, meloxicam (1 mg/kg; s.c., Boehringer Ingelheim) was administered before and
after surgeries. The rats were positioned in a Kopf stereotaxic device designed for cannula
implantation. Five-millimeter stainless steel guide cannula were implanted bilaterally into the
DH for the following coordinates: AP: -4.3 mm L: ± 2.8 mm DV: -2.5 mm from the dural
surface, or the VH in the following coordinates: AP: -5.6 mm from bregma, LM: ± 5 mm, DV: 6.8 mm from the dural surface (Figure 3). The guide cannula was secured firmed by jeweler’s
screws and dental acrylic cement. Post-surgery rats were single housed and behavioural tests
began after one week of recovery.
A

B
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Figure 3 Visual representation of surgical guide cannulas for A) Dorsal hippocampus and B) Ventral hippocampus.

2.4 Intra-VH/DH micro infusions
Intra-DH or -VH micro infusions of either vehicle (VEH, chremophore, NaCl 0.9%
mixture) or THC (100 ng/0.5μl) were performed prior to the start of behavioural experiments. A
total volume of 0.5 μl per hemisphere was delivered via an injector over a period of 1 minute.
Microinjectors were left in place for an additional 1-minute following infusion to ensure
adequate diffusion from the tip.

2.5 Behavioural Testing
2.5.1 Novel Object Recognition. This task measures the ability of the rat to discriminate
between a familiar object previously encountered and a novel object. Normal rats will spend
more time exploring the novel as opposed to the familiar object. Rats were tested in an 80 cm x
80 cm open roofed arena. They were habituated to the test arena for 20 minutes 1 day before
testing. There are two trials in this test, each three minutes long. The first trial is the acquisition
trial, where each rat was placed in an arena containing two identical objects in the far corners, 15
cm from the side wall. The rats were freely able to explore the objects after which there was a
one-hour delay period before the next trial. During this delay period rats were placed back in
their home cage. During the second trial one object was replaced by a novel object in the same
location as the previous object. Between all rats both the role (novel or familiar) and relative
position of the object was counterbalanced. Object exploration was considered when the head of
the rat was facing the object and/or the rat was sniffing the object. Times spent in exploration
were videotaped with a video-tracking software (ANY-maze; Stoelting). N: VH-VEH:9, VHTHC:10, DH-VEH:11, DH-THC:9
2.5.2 Spatial Object Recognition. This paradigm measures the ability of rodents to
discriminate between on object in a familiar spatial position versus an object in a novel spatial
position. Similarly, with novel objection recognition, normal rats will explore the object located
in the novel position. Rats were tested in an 80 cm x 80 cm open roofed arena. This paradigm
follows the same protocol as novel objection recognition with one notable difference. During the
second trial instead of replacing one object with a novel object, one of the objects from the first
trial will be moved to a different location in the arena. Time spent in exploration were
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videotaped with a video-tracking software (ANY-maze; Stoelting). N: VH-VEH:8, VH-THC:8,
DH-VEH:9, DH-VEH:8
2.5.3 Object Recognition in Temporal Order. This task measure temporal order memory
otherwise known as the ability to distinguish past experiences in the order in which they
occurred. Rats are habituated to the same arena used for novel object recognition 24 h before
testing day. This test consists of two acquisition trials, followed by a test trial. The first trial is
the same as the trial described in novel object recognition, where the rats can freely explore two
identical objects. Following the one-hour delay period, during the second trial rats are placed
back into the arena but the objects from the previous trial have been switched with a different set
of identical objects. After another one-hour delay period rats are placed back into the arena. This
time, one of the two objects will be the object from the first trial and the other will be the object
from the second trial. Between all rats both the role (first or second) and relative position of the
object was counterbalanced. Object exploration was considered when the head of the rat was
facing the object and/or the rat was sniffing the object. Times spent in exploration were
videotaped with a video-tracking software (ANY-maze; Stoelting). N: VH-VEH:10, VH-THC:9,
DH-VEH:8, DH-THC:8
2.5.4 Spontaneous Alternation Task. This task measures for spatial working memory. A
Y-maze was used for this test. During the beginning of this task each rat is placed at the end of
one arm facing the wall. All rats started in the same arm. For 15 minutes each rat is freely able to
explore and alternate between arms. Arm entry was considered when roughly 80% of a rat’s
body was in one arm. A set of alternations was defined as entry into all three arms consecutively.
Each trial was video recorded. N: VH-VEH: 10, VH-THC:10, DH-VEH: 9, DH-THC:8
2.5.5 Social motivation and social cognition. Rats were tested using a social interaction
procedure as described previously (Loureiro et al., 2015). This task assesses socially motivated
behaviour as well as social recognition memory. Rats are habituated to the 3-chamber apparatus
for 13 minutes a day before testing. Testing consisted of two successive 8-minute phases. The
initial phase tests for social motivation. In this phase, rats are placed in the centre chamber of the
apparatus. The other two chambers contain either a stranger male rat enclosed in a small wire
cage, or an empty wire cage. Time spent with the stranger rat and empty cage was measured. In
the next phase, the empty cage now contained a new stranger rat and as such, the rat from the
first phase becomes the familiar rat. Time spent with the stranger rat and familiar rat were
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measured. The locations of the stranger rat versus the familiar rat was counterbalanced between
the left and right chambers. Time exploration was analyzed using a video-tracking system
(ANY-maze; Stoelting). After each test, chamber and cages were cleaned with a 50% ethanol
solution to avoid odour cue biases. N: VH- VEH: 8, VH-THC: 10, DH- VEH: 7, DH-THC: 10
2.5.6 Light dark box. This task measures for anxiolytic or anxiogenic- like behaviours. It
is based upon a rat’s natural aversion to brightly lit environments. The test apparatus consisted of
two compartments measured at 50 x 25 x 37 cm. Between the compartments was a 10 cm x 10
cm door. One compartment was dark, covered by a black lid (the dark box), while the other side
was light, uncovered and brightly illuminated with a lamp located 120 cm above apparatus floor
(the light box). At the start of the experiment, a rat was placed in the light box facing the wall,
across from the entry to the dark box. The rat was freely allowed to explore both compartments
for a total of 8 minutes. Total time spent in the light versus dark box, first latency from light box
to enter dark box and latency time to enter the light box from dark box (latency to second
transition) were measured. A zone entry was considered with 80% of the rat’s body was in the
zone. Experiments were recorded using a video-tracking software (ANY-maze; Stoelting). N:
VH-VEH: 14, VH-THC:12. DH-VEH:9, DH-THC:11
2.5.7 Context-independent fear conditioning. This paradigm measures a rat’s ability to
distinguish between a fear conditioned or unconditioned stimuli. Rats were first habituated to the
fear boxes 24 h before conditioning. During conditioning one of two odours, almond or
peppermint, were presented. The odour was paired with a subthreshold level (1 sec, 0.4 mA) foot
shock to become the conditioned stimulus (CS+). Testing day occurred 24 h after conditioning.
During the test phase, rats were re-exposed CS+. Time freezing was recorded for 5 minutes using
a video-tracking software (ANY-maze; Stoelting). N: DH-VEH: 8, DH-THC: 9, VH-VEH: 8,
VH-THC: 7
2.5.8 Open field test. Rats were placed in an automatic open field activity chamber (San
Diego Instruments, San Diego, CA, USA) for 30 minutes. Distance travelled and time spent in
the centre versus residual area was recorded and analyzed. N: VH-VEH:8, VH-THC:8, DHVEH:8, DH-THC:9
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2.6 Protein Isolation, Quantification and Western Blots
Prior to sacrificing rats were given a final dose of THC of vehicle. Rats were sacrificed
by giving an overdose of sodium pentobarbital (240 mg/kg, i.p., EuthanylTM). They were then
decapitated, brains harvested and flash frozen. Coronal sections (98 μm thick) of either the VH
or DH were cut on a cryostat and slide mounted. Bilateral micro-punches of either hippocampal
region was obtained for protein isolation. Tissue was collected adjacent to but excluding the site
of injection. Protein was isolated using a lysis buffer and quantification was performed using a
bicinchoninic acid assay (BCA assay).
For the western blot procedure total protein samples underwent SDS polyacrylamide gel
electrophoresis at 120 V, followed by a transfer to a nitrocellulose membrane. The membranes
were blocked using a 2.5% non-fat dry milk in TBST solution. Afterwards, the membranes were
placed in a 2.5% BSA in TBST solution and probed with the following antibodies with their
corresponding dilutions: p-ERK1/2 (1:1000; Cell Signalling Technology), total ERK 1/2
(1:2000; Cell Signalling Technology), p-p70S6 Kinase (1:1000; Cell Signalling Technology),
total p70S6 Kinase (1:1000), Alpha-tubulin (1:10,000; Sigma-Aldrich) (loading control). The
membranes were left overnight at 4 C. Species appropriate secondary antibodies were used at a
dilution of 1:10,000 in a 2.5% non-fat dry milk TBST solution, and membranes scanned using a
Licor scanner.

2.7 Histology
Rats were sacrificed, and brains were harvested and sliced using the method mentioned
previously. They were later stained with a cresyl violet dye as described in Loureiro et al.,
(2015).

2.8 Statistical Analysis
All analysis was done using SPSS (IBM SPSS Statistical Package Version 23), beginning
with checking for normal distribution using the Kolmogorov-Smirnov test. The behavioural and
electrophysiology data was analyzed using t-tests, or ANOVA where appropriate. Densitometry
values for western blots were obtained with the Licor Image Studio Lite software, normalized to
alpha-tubulin and analyzed with t-tests. Confidence Interval was set to 95%, p< 0.05.
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3 Results
3.1 Behavioural Results

Novel Object Recognition

First of all, short-term memory was measured of adult rats who received micro-infusions
of THC or VEH in the DH or VH with the novel object recognition paradigm. Two-way repeated
measures ANOVA revealed a significant main effect of treatment in the DH on recognition index
(F (224) = 11.845, p<0.05). Similarly, there was also a significant main effect of treatment for the
VH groups (F (252) = 7.443, p<0.05). Intra-VH and intra-DH THC treatment induced deficits in
short-term memory deficits compared to the VEH groups (Figure 4).
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Figure 4 Novel Object Recognition. A) Schematic for novel object recognition paradigm. B) THC DH and VH
infused animals displayed no preference for novel or familiar objects. N: VH-VEH:9, VH-THC:10, DH-VEH:11,
DH-THC:9, repeated measures ANOVA; *Indicated p<0.05, Error bars represent standard error of the means
(SEMs).

Spatial Object Recognition
Next spatial short-term memory was measured of adult rats who received micro-infusions
of THC or VEH in the DH or VH with the spatial novel object recognition paradigm. Two-way
ANOVA revealed no significant main effect of treatment between the VH groups (F (156) = 3.16,

22

p>0.05), however there was a significant effect of treatment between the DH groups (F (557) =
37.295, p<0.05). Intra-DH THC treatment only induced deficits in spatial short-term memory
compared to the DH VEH treated group (Figure 5).
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Figure 5 Spatial Object Recognition. A) Schematic for spatial object recognition paradigm. B) THC infused in the
DH caused rodents to spend more time exploring the object in the familiar position as opposed to the object in the
novel position. N: VH-VEH:8, VH-THC:8, DH-VEH:9, DH-VEH:8, repeated measures ANOVA; *Indicated
p<0.05. Error bars represent standard error of the means (SEMs).
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Objects in Temporal Order
Next potential differences in temporal order memory was measured between VEH and
THC in VH or DH using the objects in temporal order paradigm. Two-way ANOVA revealed a
significant effect of treatment between the DH groups (F (277) = 26.236, p<0.05) and similarly
there was also a significant effect between the VH groups (F (451) = 13.674, p<0.05). Intra-DH
and VH THC treatment induced deficits in temporal order memory comparing to the VEH VH
and DH treated groups (Figure 6).
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Figure 6 Objects in Temporal Order. A) Schematic of the paradigm. B) Rodents with THC infused in either DH or
VH displayed no significant preference for either object. N: VH-VEH:10, VH-THC:9, DH-VEH:8, DH-THC:8,
repeated measures ANOVA; *Indicated p<0.05. Error bars represent standard error of means (SEMs).
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Spontaneous Alternations
Working memory differences between intra-VH and DH, THC and VEH groups was
measured using the spontaneous alternations paradigm. Thus far, all analysis between VH and
DH have been performed separately and to keep this consistent, t-tests were utilized to measure
for significant differences. Two-tailed t-test revealed a significant difference between the intraVH THC and VEH treated animals (t (18) = -4.936, p<0.05) but no significant different between
the intra-DH THC and VEH treated animals (t (15) = -1.496, p>0.05). Intra-VH THC treatment
but not DH THC treatment induced working memory deficits when compared to the VEH
treatment (Figure 7).
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Figure 7 Spontaneous Alternations. A) Schematic of Y-maze. B) THC infused in VH caused a significant reduction
in alternations. N: VH-VEH: 10, VH-THC:10, DH-VEH: 9, DH-THC:8, t-tests; *Indicated p<0.05. Error bars
represent standard error of means (SEMs).
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Social Interaction
To test for sociability and social cognition between intra-VH/DH THC and VEH groups,
the social motivation and recognition tests were utilized. For the intra-DH groups, all groups,
regardless of treatment, spent a significantly longer amount of time exploring the stranger rat as
opposed to the empty box. A main effect for treatment was not observed (F (399) = 0.385, p>0.05).
Similarly, using a two-way ANOVA to compare the VH treatment groups, a significant main
effect for treatment was not observed (F (980) = 1.264, p>0.05). THC did not induce deficits in
social motivation (Figure 8). Two-way ANOVA between the DH treatment groups, for the social
recognition test, demonstrated no main effect for treatment (F (43) = 0.071, p>0.05). However,
between the VH treatment groups a significant main effect for treatment was noted (F (7877) =
8.225, p<0.05). Intra-VH THC treatment only induced deficits in social recognition memory
(Figure 8).
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Figure 8 Social Interaction. A) Schematic of social interaction arena. B) Social Motivation test: All rodents spent
significantly longer time exploring the stranger rat as opposed to the empty box. C) Social Recognition test: Rodents
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that received THC infusions in the VH displayed no preference for stranger or familiar rat. N: VH- VEH: 8, VHTHC: 10, DH- VEH: 7, DH-THC: 10, repeated measures ANOVA; *Indicated p<0.05, Error bars represent standard
error of means (SEMs).

Light/Dark Box
To measure levels of anxiety between THC and VEH groups, the light/dark test was used
(Figure 9). Two-tailed t-tests found no significant differences in transition to first latency
between THC and VEH in VH (t (28) = -0.382, p>0.05) or DH (t (20) = -0.642, p>0.05). A
significant increase in the transition to second latency was found between intra-VH THC and
VEH treated animals (t (14) = 3.467, p<0.05) but not in intra-DH treated animals (t (21) = 0.158,
p>0.05). Finally, repeated measures ANOVA found no main effect for treatment in time spent
between light side and dark side for VH (F (406) =1.035, p>0.05) and DH (F (589) = 2.324, p>0.05).
All groups spent more time in the dark side as opposed to the light side (Figure 9).
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Figure 9 Light dark box. A) No significant difference from transitioning from light to dark side (first transition) B)
Rodents with THC infusion in the VH spent a significantly longer time transitioning from dark side to light side
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(second transition). C) Schematic for light/dark box paradigm. D) All rodents spent a significantly longer time in
dark box as opposed to light box. N: VH-VEH: 14, VH-THC:12. DH-VEH:9, DH-THC:11, t-tests, repeated
measures ANOVA; *Indicated p<0.05, Error bars represent standard error of means (SEMs).

Fear Conditioning
To measure for affective learning and memory between THC and VEH groups, contextindependent fear conditioning paradigm was utilized. Similar to the spontaneous alternations
paradigm, t-tests were utilized to measure for significant differences in fear expression. Twotailed t-test found a significant increase in percent freezing between intra-VH THC and VEH
treated animals (t (13) = 4.248, p<0.05). No significant differences were observed between intraDH THC and VEH treated animals (t (15) = 0.259, p>0.05). Intra-VH THC animals only
displayed an increase in emotional saliency (Figure 10).
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Figure 10 Context independent fear conditioning. A) Schematic for fear conditioning paradigm. B) Significant
increase in freezing observed in intra-VH THC treated animals only. N: DH-VEH: 8, DH-THC: 9, VH-VEH: 8, VHTHC: 7; t-tests, *Indicated p<0.05, Error bars represent standard error of means (SEMs).

Open Field
The open field test was utilized to determine deficits in locomotion and anxiety levels
(Figure 11). Two-tailed t-tests determined no significant difference in total distance travelled for
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intra-VH groups (t (14) = -0.781, p>0.05) and intra-DH groups (t (15) = 1.510, p>0.05).
Furthermore, repeated measures ANOVA determined no significant differences in treatment
between distance travelled in the periphery vs. center in intra-VH groups (F (549998) = 1.610,
p>0.05) and intra-DH groups (F (349156) =1.029, p>0.05). All groups spent a longer amount of
time travelling in the periphery than in the center.
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Figure 11 Open field maze. A) No significant differences in total distance travelled between all groups. B) All
groups spent significantly longer in the periphery than the center. C) Representative pictogram of intra-VH VEH
treated rat’s movement pattern over 30 minutes. D) Representative pictogram of intra-DH VEH treated rat’s
movement pattern over 30 minutes. E) Representative pictogram of intra-VH THC treated rat’s movement pattern
over 30 minutes. F) Representative pictogram of intra-DH THC treated rat’s movement pattern over 30 minutes. N:
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VH-VEH:8, VH-THC:8, DH-VEH:8, DH-THC:9; t-tests, repeated measures ANOVA, *Indicated p<0.05, Error bars
represent standard error of means (SEMs).

3.2 In vivo Electrophysiology Results

Single Unit Firing and Bursting data
To determine whether THC infusions in the DH or VH affected neuronal activity in the
PFC, electrophysiology was utilized. After intra-VH VEH treatment, 60% of mPFC cells
increased, 30% of cells decreased and 10% displayed no change (Figure 12 top left). Intra-VH
THC treatment caused 36% of cells to increase firing, 44% to decrease and 20% displayed no
change (Figure 12 top right). Intra-DH VEH treatment caused 46% of cells to increase, 37% to
decrease and 16% displayed no change in firing (Figure 12 bottom left). Finally, intra-DH THC
treatment caused 44% of cells to increase firing, 41% to decrease in firing and 15% displayed no
chance (Figure 12 bottom right).
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Figure 12 Single Unit cell firing changes after THC or VEH treatment.
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Cell firing and bursting activity was measured in the mPFC using single unit in vivo
electrophysiology (Figure 13). Two-tailed t-test found cells decreasing firing after intra-VH THC
treatment was significant compared to the VEH group (t (21) = -4.126, p<0.05) and cells
increasing firing after intra-DH THC treatment was significant compared to the VEH treated
group (t (32) = 6.051, p<0.05) (Figure 13). Cells with a decrease in bursting activity after intra-VH
THC treatment was significant compared to the VEH group (t (23) =-2.255, p<0.05) (Figure 13).
Additionally, cells increasing in bursting activity after intra-DH THC treatment was significant
compared to the VEH group (t (28) = 4.104, p<0.05).
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Figure 13 Single Unit In-vivo Electrophysiology in mPFC. A) Intra-VH THC treatment induced a significant
decrease in cell firing and intra-DH THC treatment induced a significant increase in cell firing. B) Intra-VH THC
treatment induced a significant decrease in cell bursting and intra-DH THC treatment induced a significant increase
in cell firing. C) Representative histogram of mPFC cell decreasing cell firing after THC treatment in VH. D)
Representative histogram of mPFC cell increasing firing after THC treatment in DH. E) Raw spike firing before
intra-VH THC micro infusion. F) Raw spike firing after intra-VH THC micro infusion. G) Raw spike firing before
intra-DH THC micro infusion. H) Raw spike firing data after intra-DH THC micro infusion. N: VH-VEH:19, VHTHC:13, DH-VEH:19, DH-THC:8; t-tests, *Indicated p<0.05, Error bars represent standard error of means (SEMs).
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Furthermore, two-tailed t-tests revealed cells that increased in firing after intra-VH THC
treatment was not significant (t (26) = 0.469, p>0.05) and neither were cells that decreased in
firing after intra-DH THC treatment (t (31) = -2.033, p>0.05). There was also no significance with
cells that increased in burst firing after intra-VH THC treatment (t (20) = 2.012, p>0.05) or cells
that decreased bursting activity after intra-DH THC treatment (t (25) =-1.629, p>0.05) (Figure 14).
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Figure 14 Single Unit In-vivo Electrophysiology in mPFC. A) No significant changes for cells that increased firing
after intra-VH THC treatment or decreased firing after intra-DH THC treatment. B) No significant changes in cells
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that increased in bursting activity after intra-VH THC treatment or decreased after intra-DH THC treatment. N: VHVEH:19, VH-THC:11, DH-VEH:19, DH-THC: 6; t-tests, Error bars represent standard error of means (SEMs).

Synchronized Oscillatory Activity
Brain wave oscillatory activity is often disrupted after THC treatment as well as in
various mental health disorders such as schizophrenia. Two-tailed t-test determined a significant
decrease in beta oscillations in intra-VH THC treated animals compared to its VEH group (t (55) =
-2.303, p<0.05) but no such difference between the DH treated animals (t (20) = -1.207, p>0.05).
There was also a significant decrease in gamma oscillations in the intra-VH THC treated animals
compared to the VEH group (t (47) = -2.465, p<0.05) but no such difference between the DH
treated animals (t (37) = 0.616, p>0.05) (Figure 15).
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Figure 15 Synchronized oscillatory activity in mPFC. A) Synchronized waveform B) Representative heat map of
beta oscillations decreasing after THC treatment in VH. C) Representative heat map of gamma oscillations
decreasing after THC treatment in VH. D) Intra-VH THC treatment only caused a significant decrease in beta and
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gamma oscillatory activity. N: VH-VEH: 29, VH-THC:18, DH-VEH: 21, DH-THC: 18; t-tests, *Indicated p<0.05,
Error bars represent standard error of means (SEMs).

No significant differences in delta (t (55) = 1.230, p>0.05), theta (t (52) = 0.527, p>0.05),
and alpha (t (52) = -0.706, p>0.05) oscillations between the VH THC treated and VH VEH treated
animals. Additionally, delta (t (36) = 0.748, p>0.05), theta (t (37) = -0.649, p>0.05), and alpha (t (41)
= -0.666, p>0.05) oscillations were not significantly different between the DH THC and DH
VEH groups (Figure 16).
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Figure 16 Synchronized Oscillations in mPFC. A) Significant decrease in beta and gamma oscillations only in intraVH THC treated animals. B) No significant differences in oscillatory activity in intra-DH treated animals. T-tests,
*Indicated p<0.05, Error bars represent standard error of means (SEMs).
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Desynchronized Oscillatory Activity
Two-tailed t-test revealed a significant decrease in alpha oscillations in the intra-DH THC
group compared to the VEH group (t (24) = -2.207, p<0.05), but no significant differences
between the intra-VH THC and VEH groups (t (34) = 0.262, p>0.05) (Figure 17).
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Figure 17 Desynchronized oscillatory activity in mPFC. A) Desynchronized waveform. B) Representative heat map
demonstrating a decrease in alpha oscillations after intra-DH THC treatment. C) Intra-DH THC treatment only
caused a significant decrease in alpha oscillatory activity. N: VH-VEH: 28, VH-THC: 8, DH-VEH:20, DH-THC: 6;
t-test, *Indicated p<0.05, Error bars represent standard error of means (SEMs).

Furthermore, no significant differences were found in delta (t (36) = 0.558, p>0.05), theta
(t (31) = 1.631, p>0.05), beta (t (35) = 0.650, p>0.05), and gamma (t (30) = 0.041, p>0.05) oscillatory
activity between the intra-VH THC and VEH groups. There were also no differences found in
the delta (t (9) = 0.182, p>0.05), theta (t (26) = -1.985, p>0.05), beta (t (9) = 1.216, p>0.05) and
gamma (t (28) = 1.262, p>0.05) oscillations between the intra-DH THC and VEH groups (Figure
18).
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38

3.3 Molecular Results

To determine any changes in protein expression that may have contributed to cognitive or
emotional deficits, western blots on VH and DH tissue was performed. Two-tailed t-test revealed
a significant increase in phosphorylated ERK 1 (t (6) = 2.542, p<0.05) and ERK 2 (t (6) =2.445,
p<0.05) expression in intra-VH THC treated animals compared to VEH. There were no
significant differences in phosphorylated ERK 1 (t (6) = 0.374, p>0.05) or ERK 2 (t (6) =2.438,
p>0.05) levels between intra-DH THC and VEH groups (Figure 19).
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Figure 19 THC on phosphorylated ERK 1/2 levels. Representative western blot for pERK 1 (44 kDa) and pERK 2
(42 kDa) along with alpha-tubulin (55 kDa) expression in VH and DH tissue (top). A significant increase in pERK
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1/2 levels in the intra-VH THC treated animals. N=4, t-tests, *Indicated p<0.05, Error bars represent standard error
of means (SEMs).

Two-tailed t-test revealed no significant differences in total ERK 1 (t (6) = 0.199, p>0.05)
and ERK 2 (t (6) = 0.183, p>0.05) levels between intra-VH THC and VEH groups. There were
also no significant differences in total ERK 1 (t (6) = -0.152, p>0.05) and ERK 2 (t (6) = -0.234,
p>0.05) levels between intra-DH THC and VEH groups (Figure 20).
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Figure 20 THC on total ERK 1/2 levels. Representative western blot for ERK 1 (44 kDa) and ERK 2 (42 kDa) along
with alpha-tubulin (55 kDa) expression in VH and DH tissue (top). No significant differences in ERK 1/2 levels
between VEH and THC treated animals. N=4, t-tests, *Indicated p<0.05, Error bars represent standard error of
means (SEMs).
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The ratios between phosphorylated ERK 1 and 2 with total ERK 1 and 2 was also taken
(Figure 21). Two-tailed t-test revealed no significant difference between intra-VH THC and
VEH groups with pERK1: tERK1 levels (t (6) = 0.676, p>0.05) and pERK2:tERK2 levels (t (6) =
0.805, p>0.05). There were also no significant differences between intra-DH THC and VEH
groups with pERK1: tERK1 levels (t (6) = 0.321, p>0.05) and pERK2: tERK2 levels (t (6) = 2.113,
p>0.05).
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Figure 21 THC on pERK 1/2: tERK 1/2 levels. No significant differences between pERK 1/2: tERK 1/2 ratio
between VEH and THC treated animals. N= 4; t-tests, Error bars represent standard error of means (SEMS).

Moreover, p70S6 kinase protein expression, involved in learning and memory was also
measured (Figure 22). Two-tailed t-test revealed a significant increase in phosphorylated p70S6
kinase expression in intra-VH THC treated animals compared to the VEH group (t (3) = 3.177,
p<0.05). No significant difference in protein expression between the intra-DH groups (t (6) =
1.365, p<0.05).
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Figure 22 THC on phosphorylated p70S6 kinase levels. Representative western blot for phosphorylated p70S6 (70
kDa) and alpha-tubulin (55 kDa) expression in VH and DH tissue (top). Significant increase in phopho-p70S6
expression in intra-VH THC treated animals only. N=4; t-tests, *Indicated p<0.05, Error bars represent standard
error of means (SEMs).

Two-tailed t-test revealed no significant differences in total p70S6 kinase between intraVH VEH and THC groups (t (6) = 0.948, p>0.05) as well as between intra-DH VEH and THC
groups (t (6) = 0.784, p>0.05) (Figure 23).
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Figure 23 THC on total p70S6 kinase levels. Representative western blot for total p70 (70 kDa) and alpha-tubulin
(55 kDa) expression in VH and DH tissue (top). No significant differences in p70 kinase levels between VEH and
THC treated animals for both VH and DH groups. N=4, Error bars represent standard error of means (SEMs).

Similarly, with ERK the ratio of phosphorylated p70S6 kinase to total p70S6 kinase
between the VEH and THC groups was compared (Figure 24). There were no significant
differences in the ratio between intra-VH VEH and THC groups (t (6) = 2.176, p>0.05) as well as
no significant difference between intra-DH VEH and THC groups (t (6) = 0.860, p>0.05).
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Figure 24 THC on p-p70: p70 kinase levels. No significant differences between p-p70: p70 kinase ratio between
VEH and THC treated animals. N= 4; t-tests, Error bars represent standard error of means (SEMS).

4 Discussion
The current findings demonstrate, for the first time several dissociative effects of THC
within distinct ventral vs. dorsal hippocampal sub-regions (Figure 25). This data improves our
understanding of the precise brain mechanisms involved in the modulation of THC-induced
cognitive and emotional side-effects, and how this in turn may lead to various mental healthrelated complications. Specifically, it was observed that THC directly in the dorsal hippocampus
primarily induced short-term cognitive learning and memory deficits, whereas THC in the
ventral hippocampus induced several deficits in affective/emotional processing as well as deficits
in higher order cognitive functioning. Given my initial hypothesis that the effects of THC within
the hippocampus would dissociate along cognitive vs. emotional impairments across dorsal vs.
ventral regions, respectively, these findings suggest a more expansive role for both the dorsal and
ventral hippocampus in terms of THC-induced cognitive processing deficits, and a selective role
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for the ventral hippocampus specifically in the context of affective/emotional-related sideeffects.
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Figure 25 Summary of research findings

Intra-DH THC treatment caused deficits in short-term memory and cognition

Behavioural results demonstrated that THC infusions into the DH caused deficits in
short-term memory, both spatial and non-spatial. These findings are consistent with the current
literature, which has suggested that acute THC exposure causes deficits in short-term memory.
Specifically, systemic injections of THC are known to cause deficits in novel object recognition
(Kasten et al., 2017). Thus, it can be concluded that short-term memory impairments from THC
exposure is likely related to effects directly within the DH.
Similarly, JWH-018 a synthetic cannabinoid agonist, impaired cognitive functioning,
shown in a novel object recognition paradigm (Barbieri et al., 2016). In-vitro electrophysiology,
using JWH-018 exposure in hippocampal slices negatively evoked LTP and synaptic
transmission, thereby demonstrating that interference of hippocampal memory transmission
causes deficits in cognitive functioning (Barbieri et al., 2016). While the LTP was not recorded
in the hippocampus, similar behavioural deficits as JWH-018 was observed and it can be
speculated that there could be a decrease in LTP after THC treatment in the DH.
Moreover, the medial temporal lobe, specifically the hippocampus, is critical for memory
encoding. The hippocampus is involved in episodic memory consolidation and hippocampal
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neural hyperactivity resulting from marijuana consumption has been associated with deficits in
episodic memory (Ilan et al., 2004, Nestor et al., 2008). Results from the temporal order
paradigm demonstrated deficits in episodic memory after acute infusions of THC in the DH.
Therefore, cognitive deficits related to exposure to high concentrations of THC might be linked
to the effects of THC within the DH.
The hippocampus is involved in spatial working memory deficits mediated by THC
(Mishima et al., 2002, Wise et al., 2009). In the present project, significant deficits in working
memory during intra-DH THC treatment was not observed, however this deficit has been
reported previously in the literature. For example, using a radial maze paradigm, intra-DH THC
treatment has been shown to cause deficits in working memory (Mishima et al., 2002, Wise et
al., 2009). Given that a more simplistic spontaneous alternations paradigm was used in the
present study, it is possible that more complex tasks (such as the radial arm maze) may be
necessary to observe these subtle deficits.
Additionally, there was an observation of a decrease in alpha desynchronization after
intra-DH THC treatment. Desynchronized alpha oscillations in the frontal lobe has been shown
to predict successful memory encoding and retrieval (Parish et al., 2018). Hence, it can be
speculated that intra-DH THC treatment causes deficits in short term memory through reduced
desynchronization in alpha oscillatory activity. A major caveat is the total N for desynchronized
alpha oscillations is low, a large amount of desynchronized activity during electrophysiology
was not witnessed. Additionally, all recordings were taken from anaesthetized animals and there
is a possibility that our results may have differed had recordings been taken in awake animals.
Therefore, a correlational relationship between our alpha oscillatory results with the behavioural
results as opposed to causational is assumed.
Nevertheless, the reduction in desynchronized alpha activity may prove to be detrimental
should it occur chronically. Abnormal desynchronized alpha activity over areas of the prefrontal
cortex can pose as a risk factor for Alzheimer’s disease (AD) (del Val et al., 2016). This may
indicate that chronic exposure to THC may increase risk of developing AD later in life.
With regards to protein expression, addictive and non-addictive drugs alike activate the
ERK signaling pathway (Valjent et al., 2004). While it was not significant, there was a trend of
an increased phosphorylated ERK2 after intra-DH THC treatment but not ERK1. While there are
many similarities between the isoforms, ERK 2 is more prevalent in the brain and is often
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involved in spatial learning and memory, more so than ERK 1 (Indrigo et al., 2010). This may
indicate a role for ERK2 in the modulation of cognitive deficits seen during THC micro
infusions to the DH. Total ERK 1/2 levels had no changes after acute THC treatment in the DH,
meaning acute doses of THC may have post-translational effects on ERK levels. There were no
significant differences in the pERK 1/2: tERK 1/2 ratio however, there is a notable increase in
ERK2. Perhaps if the N was increased it could decrease the variability seen in order to give a
significant p value.
Interestingly, ERK activity may differ depending on the method of activation. ERK 1/2
activation in the hippocampus, via an excitatory neuropeptide known as orexin-A, can reverse
impairments in spatial learning and memory (Zhao et al., 2014). However, Zhao et al., (2014)
specifically looked at protein expression in the dentate gyrus while the current study looked at
protein expression in the CA1 region of the hippocampus. This may suggest potential differential
effects dependent on the specific hippocampal region.
Lastly, there were no significant deficits in emotional learning and memory during intraDH THC treatment. However, there was a slight increase in locomotion after THC micro
infusions in the DH, which could indicate a slight decrease in anxiety. As stated earlier, the DH
is more involved in cognitive functioning, however CB1R activation in the DH has been noted to
cause anxiolytic effects (Lisboa et al., 2015). No significant anxiolytic effects were found during
CA1 dorsal THC micro infusions, yet Lisboa et al., (2015) found anxiolytic effects during CB1R
activation specifically in the dentate gyrus, demonstrating potentially functional differences
between the CA1 and dentate gyrus regions of the DH.
Interestingly, in addition to potential anxiolytic effects, increased activation of CB1
receptors in the DH can also elicit anti-depressant effects (McLaughlin et al., 2007). Therefore,
the DH may be a therapeutic target to alleviate depressive-like symptoms. The present study did
not utilize a paradigm like the forced swim test, which is often used to model depression.
Regardless, the current study targeted the CA1 region whereas McLaughlin et al., (2007)
targeted the dentate gyrus. Therefore, if there are differences between the CA1 and dentate
gyrus, the present study may not have seen anti-depressive effects during the forced swim test
paradigm.
Additionally, the DH interacts with the mPFC in the formation of fear and reward-related
memories (Han et al., 2014, Lisboa et al., 2015, Yan et al., 2014). Yang et al., (2014) determined
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that interactions between the DH and mPFC are required for fear memory formation during a
context dependent fear conditioning paradigm. In regard to proteins, P70S6 kinase is activated in
the dorsal hippocampus after context dependent fear retrieval (Gafford et al., 2013). There were
no significant differences in p70S6 kinase protein expression between the VEH and THC DH
treated groups. Behaviourally, there were no significant deficits of intra-DH THC treatment in
the context-independent fear conditioning paradigm. This signifies that different neural
mechanisms may be required for context dependent vs. independent fear-memory processing.
Our results revealed that the DH may not be involved in context independent fear conditioning,
while previous studies suggest its involvement in modulating context dependent fear
conditioning (Gafford et al., 2013, Yang et al., 2014).
It is also entirely possible that the dorsal hippocampal- prefrontal cortex pathway is not
involved in the acquisition of fear memories. Activation of dorsal hippocampal neurons that
directly project to the prefrontal cortex strengthen the reconsolidation of fear memories (Ye et
al., 2017). From our electrophysiology results, there was a significant increase in cell firing and
bursting activity after intra-DH THC treatment. Prefrontal bursting activity has been shown to
modulate emotional learning and memory (Laviolette and Grace, 2006) and as such an increase
should have strengthened fear memories. However, this effect was not witnessed behaviourally,
possibly because THC was infused into the DH right before the acquisition phase of the fear
memory. Thus, intra-DH THC treatment had no effect on the acquisition of fear memories but it
may modulate fear memory consolidation. Future studies are required to resolve these questions.

Intra-VH THC treatment caused deficits in emotional learning and higher order cognitive
functioning

Acute injections of THC in mice have been reported to cause an increase in anxiogenic
behaviours (Kasten et al., 2017). This increase in anxiety is modulated by CB1 receptors in areas
of the limbic cortex like the amygdala and hippocampus (Bhattacharyya et al., 2017). High doses
of THC infusions in the VH specifically have been shown to cause anxiogenic responses (Rubino
et al., 2008). Using the light/dark box paradigm, it was observed that intra-VH THC treatment
caused an increase in anxiety, in line with current literature. Additionally, through our fear
conditioning paradigm there was a significant increase in emotional saliency to aversive stimuli
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during intra-VH THC treatment. Therefore, in line with the current literature, acute local
infusions of THC in the VH caused an increase in anxiety-like behaviours.
While the present study found anxiogenic effects during the light/dark box and fear
conditioning paradigms, there weren’t any significant deficits during the open field maze. IntraVH THC treated rats did display a slight decrease in overall locomotor activity and a slight
increase in distance travelled in the periphery compared to its vehicle group, which would be
signs of an increase in anxiety. Yet, the lack of significance may have been due to
methodological issues. All rats were experimentally naïve; thus, they had not undergone a
different behavioural paradigm before the open field maze. Trained rats typically are less anxious
compared to untrained rats (Martin et al., 2001). Therefore, anxiogenic responses may not have
been detected since the control groups were untrained, prior to the open field maze task, and may
have demonstrated an unusual increase in anxiety.
With regards to single neuron and oscillatory activity, when THC was infused in the VH,
there was a significant decrease in cell firing and bursting activity in the PFC. This predicted
aberrant anxiety-like behaviours, as the PFC cell bursting activity is involved in the modulation
of emotionally salient behaviours (Laviolette and Grace, 2006). Furthermore, a decrease in
synchronized gamma oscillatory activity was observed. Gamma oscillations have been seen to
play a role in translating emotionally salient events into memories (Caliskan et al., 2018).
Additionally, during slow wave sleep, synchronized gamma oscillations bind the hippocampus
and prefrontal cortex, which is required for memory consolidation (Ferraris et al., 2018).
Therefore, THC, which caused a desynchronization of gamma waves and decrease in single
neuron bursting activity altered memory encoding and consolidation of emotionally salient
events. This in turn led to an exaggeration of emotionally salient memories.
Dysregulated emotional learning not only can exaggerate emotionally salient cues but can
also cause disruptions in stimuli that would otherwise be significant, such as sociability.
Hippocampal CB1 receptor activation via WIN-55 can induce deficits in normal social behaviour
(Loureiro et al., 2015). Thus, similarly to synthetic CB1 agonists THC micro-infused into the VH
caused deficits in social recognition memory, however they were not as adverse as WIN-55
treatment. Local WIN-55 infusions into the VH caused an attenuation in social motivation as
well as social recognition; even the effects of social recognition were more adverse as WIN-55
treated rats had a strong preference to the familiar rat as opposed to the stranger rat (Loureiro et
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al., 2015). THC treatment did not cause a strong preference or aversion to either stranger or
familiar rat, but it did diminish preference for social novelty. This is often a rewarding behaviour
for rodents. While synthetic and phytocannabinoids produce similar behavioural effects, the
former are full CB1 agonists while the later are partial CB1 agonists (Tai & Fantegrossi, 2014).
THC treatment in the VH causes deficits in reward memory formation, however the effect is not
as potent as WIN-55.
What was not expected was THC micro infusions in the VH to cause deficits in many of
the cognitive paradigms. However, there was also an increase in anxiety and emotional saliency
to aversive stimuli, therefore instead of displaying cognitive deficits, THC directly infused in the
VH may result in a decrease in novelty preference. Though it was not significant there is a slight
decrease in time exploring the novel object versus the familiar within the THC treated groups, in
all the object recognition paradigms. Additionally, THC has been shown to decrease exploratory
behaviour, also resulting in a decrease in novelty (Schreiber et al., 2018). Beta oscillations are
naturally tuned for novelty detection (Franca et al., 2014). Thus, a decrease in beta oscillations in
the mPFC following intra-VH THC treatment may have caused deficits in novelty recognition
during these tasks.
Besides a decrease in novelty detection capacity, this study observed deficits in spatial
working memory after intra-VH THC micro-infusions, despite observing no working memory
deficits during intra-DH THC treatment. Oscillatory activity in the mPFC plays a crucial role in
spatial working memory. Indeed, O’Neil et al., (2013) reported that theta oscillations in the
mPFC synchronized with theta oscillations in the VH during the modulation of spatial working
memory. In fact, the VH plays a major role in synchronizing theta oscillations in the mPFC and
VH. While significant changes in the theta band was not observed, there was a slight increase in
desynchronized theta oscillations in mPFC after THC micro-infusions in the VH. This may
suggest THC in the VH but not DH interferes with theta synchronization between the
hippocampus and mPFC, thereby causing deficits in spatial working memory. However, due to
the nature of our THC micro-infusions, recording oscillatory activity in the VH was not possible
thus, no conclusions can be drawn with regards to how THC interferes with oscillations within
the VH. Moreover, a potential limitation to our study is that electrophysiological recordings were
taken on anaesthetized animals rather than awake animals. Thus, this study may not have
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witnessed significant changes in theta oscillatory activity because the recordings were not taken
from awake animals performing a working memory paradigm.
Furthermore, there was a significant decrease in cognitive flexibility in the social
motivation task, during intra-VH THC treatment. Cognitive flexibility is another executive
function modulated by the mPFC and requires beta and gamma oscillatory functioning (Brockett
et al., 2018). Deficiency in gamma oscillatory activity in prefrontal interneurons has been
hypothesized to cause cognitive flexibility impairments (Cho et al., 2015). Though pyramidal
cells were targeted for our single unit recordings, interneurons are often dispersed within
prefrontal granule layers, and may have been a part of the LFP recordings. As such the cognitive
inflexibility observed during the social motivation task may have been correlated to the
deficiency in gamma oscillatory activity.
Moreover, there was an observation of an upregulation in phosphorylated ERK1 and 2
levels after THC treatment in the VH. As stated previously, increases in ERK activation is
common with many drugs of abuse. Additionally, ERK is involved in upregulating long-term
potentiation (LTP), required for the formation of new memories. Specifically, it is involved in
modulating emotional learning and memory and as such, it can be correlated with the
abnormalities in emotional processing. An upregulation of phosphorylated ERK 1/2 via CB1R
activation, in the VH, is correlated with an increase in emotionally salient behaviours. This study
did not witness a significant increase in total ERK levels after an acute dose of THC in the VH.
Therefore, consistent with the effects observed with acute treatments in the DH, THC locally
infused in the VH causes post-translational effects on ERK 1/2 levels.
Finally, the present study also observed a significant increase in phosphorylated p70S6
kinase protein expression after intra-VH THC treatment. P70S6 kinase is part of the mTOR
pathway, which is highly affected by THC via CB1R activation (Puighermanal et al., 2009). An
increase in p70S6 kinase in particular is associated with an increase in fear expression (Zubedat
& Akirav, 2017). Hence, it is speculated that the upregulation of p70S6 kinase from intra-VH
THC treatment is involved with the anxiogenic effects and an increased expression of fear.

Intra-VH THC treatment can produce a schizophrenia-like pathophysiology
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These deficits can also lead to developing a psychiatric disorder such as schizophrenia.
Marijuana consumption results in an increased risk of developing a psychiatric disorder (Renard
et al., 2016, Renard et al., 2018). The mediotemporal brain region is often implicated in the
modulation of memory deficits as well as the induction of psychotic symptoms (Bhattacharyya et
al., 2009). This makes it a region of interest for therapeutic interventions for many psychiatric
disorders. Hyperactivity, particularly in the hippocampus has been characterized to produce a
schizophrenia like pathophysiology (Lodge et al., 2009). In particular, it is the hyperactivity
within the ventral hippocampus that produces a similar pathophysiology to schizophrenia (Grace,
2010). Moreover, THC also affects cortical activity in the prefrontal cortex, which results in
developing or exacerbating symptoms of schizophrenia (Aguilar et al., 2016, Renard et al.,
2017). The current study has shown the hippocampus modulates neural activity in the prefrontal
cortex. Thus, the hippocampus specifically is a region of interest in finding a pharmacological
intervention for treating the symptoms of schizophrenia.
Oscillatory abnormalities in schizophrenia include a global decrease in alpha band power
but an increase in alpha band power over prefrontal areas. Both effects are linked to the positive
and negative symptoms of schizophrenia (Knyazeva et al., 2008). There were no observations in
abnormalities in alpha oscillations after intra-VH THC treatment possibly because it was only an
acute treatment, but there was a decrease in alpha power after intra-DH THC treatment. If an
increase in alpha oscillatory activity is associated with symptoms of schizophrenia, a decrease
could alleviate or prevent such symptoms. As stated previously, CB1R activation in the DH has
been seen to cause anti-depressant effects (McLaughlin et al., 2007), thus, it could be possible
for DH CB1R activation to also have anti-psychotic effects. However, further investigation is
required.
Disruptions in prefrontal gamma and beta oscillations are often seen to underlie
symptoms of schizophrenia (Uhlhaas et al., 2013). This study found reduced synchrony in
gamma and beta oscillations in the PFC, during intra-VH THC treatment which may suggest the
VH having a role in modulating schizophrenia-like symptoms. High gamma band oscillations in
particular are involved in the cognitive deficits of schizophrenia, as impairments in task
performance are accompanied by deficits in gamma oscillatory power (Grutzner et al., 2013).
While beta oscillatory activity in relation to schizophrenia has been less explored, there is
evidence to suggest deficient beta activity in patients with schizophrenia. Synchronized beta

52

activity maintains proper sensorimotor and cognitive functioning (Engel and Fries, 2010).
Patients with schizophrenia have impairments in synchronized beta activity, causing failure to
accurately predict causes of sensory perceptions, resulting in auditory hallucinations (Ford et al.,
2007). THC may increase the risk of developing schizophrenia through disrupting high
frequency oscillations in the gamma and beta range.
The present study also witnessed behavioural abnormalities in working memory and
emotional saliency, which are also common symptoms of schizophrenia. This is further evidence
that THC can increase the risk of developing the cognitive symptoms of schizophrenia. Further
behavioural paradigms are required to better test whether THC can model schizophrenia-like
symptoms. As an example, sensorimotor gating alternations like a loss of normal prepulse
inhibition is a characteristic symptom of schizophrenia and systemic injections of THC have
been shown to cause these deficits (Ibarra-Lecue et al., 2018). Prepulse disinhibition is a positive
symptom of schizophrenia and as such would be a useful measurement to obtain to determine
whether THC locally infused into the VH or DH has a role in the pathophysiology of
schizophrenia.
Finally, the current study also did not witness the appearance of any negative symptoms
of schizophrenia, from THC exposure such as social withdrawal. Slamberova et al., (2016)
demonstrated acute systemic injections of THC having no effect on social interaction. However,
this does not rule out the potential effects of THC on negative symptoms of schizophrenia.
Chronic THC exposure during adolescence has shown a decrease in social motivation (Renard et
al., 2017), which furthers the risk of developing schizophrenia in the future. All in all, it can be
speculated that the VH, but not DH playing a role in the increased risk of developing
schizophrenia from THC exposure but targeting the DH may also help to alleviate schizophrenialike symptoms.

General Conclusions and Future Directions

With the impending legalization of marijuana in Canada, it is more important than ever to
determine the potential psychopathological effects of THC exposure and understand the specific
neural mechanisms underlying these phenomena. In this thesis, it has been demonstrated that
THC, a CB1R agonist, is capable of inducing cognitive deficits in the DH whereas it causes a
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broader range of both cognitive and emotional deficits in the VH. This may indicate a larger role
of the VH for the pathophysiology of psychiatric and addictive disorders, however further
research is required to more precisely dissociate these symptom clusters.
Moving forward, future studies should work on challenging these deficits
pharmacologically. As there was an upregulation in ERK 1/2 levels, ERK inhibitors combined
with THC could be infused into the VH and DH, to determine whether THC deficits are
alleviated. A similar experimental design can be performed with p70S6 kinase inhibitors, as
there was an increase in p70S6 kinase protein levels after THC treatment in the VH.
In addition to ERK and p70S6 kinase, CB1R activation activates a variety of protein
cascades that also might be affected by THC. For example, AKT is also a protein activated
through CB1 receptors and modulates acute effects of psychosis and cognition in marijuana users
(Morgan et al., 2017). As such, changes in AKT protein expression may have been implicated in
the cognitive deficits of THC.
As stated previously the mTOR pathway is linked to the neuropsychiatric effects of THC
exposure (Renard et al., 2016), and studies have shown that blocking mTOR activation alleviates
the anxiolytic effects of THC (Puighermanal et al., 2009, Puighermanal et al., 2013). However,
mTOR activation via THC has not previously been differentiated between the VH and DH.
Additionally, whether mTOR attenuates cognitive deficits induced by THC has not been
determined. mTOR related mutations which cause an overexpression of the protein can cause
intellectual disabilities (Reijinders et al., 2017). While the study observed changes in p70S6
kinase, a downstream protein in the mTOR pathway, it would be interesting to determine
whether THC modulates mTOR expression at both a protein and/or genetic level.
While THC is a CB1R agonist, it can also activate other receptors. Chronic THC
exposure causes supersensitive coupling of serotonin 2A receptors (5-HT2A) towards inhibitory
G-proteins as well as inducing a pro-hallucinogenic molecular conformation of the receptor
(Ibarra-Lecue et al., 2018). Functional selectivity of 5-HT2A is involved in modulating the
positive symptoms of schizophrenia (Ibarra-Lecue et al., 2018). Serotonin networks are also
involved in emotion regulation (Wolf et al., 2018). Therefore, it may be possible that some of the
THC-induced behavioural deficits observed could have been due to activation of 5-HT2A
receptors and therefore, the potential role of serotonin receptor signaling is another promising
avenue for future research studies.
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Additionally, marijuana is comprised of a variety of phytocannabinoids, some of which
have opposing effects to THC. For example, CBD which is another major phytochemical found
in marijuana, has been shown to have opposite effects compared to THC and as such, may
represent a promising counteractive agent to the negative effects of THC exposure. For example,
CBD has been reported to have strong anti-psychotic properties in both clinical (Corroon &
Phillips, 2018) and pre-clinical studies (Renard et al., 2016). Moreover, it would also be
interesting to examine possible dissociable effects of CBD between the ventral and dorsal
hippocampal sub-regions. CBD has been shown to alleviate symptoms of anxiety and is noted to
be a potential treatment for anxiety disorders (Blessing et al., 2015, R de Mello Schier et al.,
2014).
The present study explored the acute effects of THC in terms of affective and cognitive
deficits in the dorsal versus ventral hippocampal sub-regions. However, it did not examine
potential effects of long-term, chronic THC exposure within these distinct hippocampal subregions. This is of significant relevance, as marijuana is initially consumed during adolescence
and can cause persistent deficits lasting into adulthood. As a potential experimental design
adolescent rats can be given chronic injections of THC for 10 days. A month later when they are
adults, cannulations can be surgically implanted to the VH or DH and the same battery of
behavioural paradigms can be performed. Electrophysiology can also be performed to determine
whether the brain pathophysiology closely resembles that of schizophrenia.
Due to the nature of our infusions, cell activity and oscillatory states in the hippocampus
could not be recorded. Synchronous theta waves are often required in the acquisition phase of
learning and memory (Parish et al., 2018). Future studies should determine whether irregular
theta oscillations in conjunction with irregular oscillatory states in the prefrontal cortex, resultant
of THC, is responsible for the deficits in learning and memory.
In summary, the data presented in this thesis sheds important new light on how THC can
differentially impact distinct anatomical regions of the hippocampal formation in the context of
marijuana-induced psychiatric side-effects. Results of these studies will have important
implications for understanding how and why chronic marijuana exposure may selectively
damage distinct regions within the hippocampus and the resulting neuropsychiatric pathology. In
addition, results from the molecular studies performed in this thesis may inform future studies as
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to the potential importance of the ERK and p70S6K signaling pathways as potential biomarkers
for increased mental health risks following marijuana exposure.
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